Ocular Therapeutix Inc (NAS:OCUL)
$ 5.8 -0.2 (-3.33%) Market Cap: 898.36 Mil Enterprise Value: 520.85 Mil PE Ratio: 0 PB Ratio: 2.20 GF Score: 78/100

Ocular Therapeutix Inc at JMP Securities Life Sciences Conference Transcript

May 15, 2023 / 07:00PM GMT
Release Date Price: $6.33 (+1.93%)
Jon Wolleben
JMP Securities LLC - Analyst

Good afternoon, everybody. My name is Jon Wolleben, senior analyst with JMP Securities. And we're pleased to have Ocular Therapeutix joining us with CEO Antony Mattessich. Thanks for joining us, Antony.

Antony Mattessich
Ocular Therapeutix, Inc. - President & CEO

Thanks for having me.

Questions & Answers

Jon Wolleben
JMP Securities LLC - Analyst

We've been talking a lot the past couple of weeks about a path forward with, primarily, OTX-TKI and a lot of questions. Would love to get an update on the program and then also the data that's upcoming, the 12-month follow-up, how we should think about that read-out.

Antony Mattessich
Ocular Therapeutix, Inc. - President & CEO

Great. Well, I mean, a lot's been happening. It's been an incredibly busy time at Ocular Therapeutix, as you might imagine. But as we move forward, things get clearer and clearer. I think one of the main areas of clarity we have now is that we

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot